Carbamazepine Tablet, Chewable
Product Images NDC 0615-8125

2 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 0615-8125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine Tabs 8125 1)

Chemical Structure (Carbamazepine Tabs 8125 1)
Chemical structure of carbamazepine, showing its molecular framework with fused aromatic rings and an amide group.*
FDA Label Image

Principal Display Panel (Carbamazepine Tabs 8125 2)

Principal Display Panel (Carbamazepine Tabs 8125 2)
Label for Carbamazepine Tablets USP (Chewable) 100 mg, provided by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes product identification, barcodes, lot number 8125, and storage instructions. It states each chewable tablet contains 100 mg carbamazepine and advises storage at 20° to 25°C (68° to 77°F). The label is marked FOR INSTITUTIONAL USE ONLY and includes space for received date and time. The product is packaged by Vangard Labs in Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.